The Valley Desk

ArticleEuropean journal of haematologyPublished

Safety and Efficacy of Teclistamab in Patients With Relapsed or Refractory AL Amyloidosis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
European journal of haematology
Published
Subject terms
Humans; Recurrence; Antibodies, Bispecific; Treatment Outcome; Retrospective Studies; Aged; Middle Aged; Female; Male; Immunoglobulin Light-chain Amyloidosis; Bispecific antibody; Al Amyloidosis
PubMed ID
39552142
PubMed Central ID
PMC11798760
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal